Latest News

STAT Plus: In a blow to Catalyst, judge recommends tossing its lawsuit against FDA

A federal court judge recommended tossing out a lawsuit filed by Catalyst Pharmaceuticals (CPRX) that accused the Food and Drug Administration of violating the law when it approved a similar medicine by a small, family-run rival company.

The move is a blow to Catalyst in its unusual battle with the agency, which has raised thorny questions about regulatory standards and the vagaries of orphan drug designations, while also playing into the heated national debate over the rising cost of prescription medicines. Investors sent its stock down nearly 12% in mid-day trading on the news.

Continue to STAT Plus to read the full story…

Source link

Related posts

Intellectually active lifestyle confers protection against neurodegeneration in Huntington's patients


Incentivise Irish-trained doctors to retain them – IMO


Effects of language background on the development of sociolinguistic awareness: the perception of accent variation in monolingual and multilingual 5-7 year old children


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World